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The Low Resolution Structure of ApoA1 in Spherical High
Density Lipoprotein Revealed by Small Angle Neutron
Scattering*□
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Spherical high density lipoprotein (sHDL), a key player in
reverse cholesterol transport and the most abundant form of
HDL, is associated with cardiovascular diseases. Small angle
neutron scattering with contrast variation was used to determine the solution structure of protein and lipid components of
reconstituted sHDL. Apolipoprotein A1, the major protein of
sHDL, forms a hollow structure that cradles a central compact
lipid core. Three apoA1 chains are arranged within the low resolution structure of the protein component as one of three possible global architectures: (i) a helical dimer with a hairpin
(HdHp), (ii) three hairpins (3Hp), or (iii) an integrated trimer
(iT) in which the three apoA1 monomers mutually associate
over a portion of the sHDL surface. Cross-linking and mass
spectrometry analyses help to discriminate among the three
molecular models and are most consistent with the HdHp overall architecture of apoA1 within sHDL.

Epidemiological studies firmly establish that circulating levels of high density lipoprotein (HDL) cholesterol and apolipoprotein A1 (apoA1),2 the major protein constituent of HDL
particles, are inversely associated with atherosclerotic heart
disease risk (1–3). Moreover, genetic studies further confirm a
strong mechanistic link between HDL and apoA1 and cardiovascular disease (4 – 8). Defined by its buoyant density characteristics, HDL represent a heterogeneous group of particles
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with varied lipid composition and protein content that participate in diverse biological functions ranging from lipid transport
to innate immune functions. For example, HDL serves as an
acceptor of cholesterol from peripheral tissue macrophages
and promotes lipid transport through delivery of cholesterol to
the liver and steroidogenic tissues (9 –11). HDL also mediates
systemic anti-inflammatory and anti-oxidant functions (12–
14), and HDL-associated proteins can play critical host defense
functions (15). ApoA1 represents nearly three-quarters of the
protein content of HDL by mass, and it plays a central functional role in facilitating the numerous biological activities of
HDL. Typically present at 2– 4 molecules/particle depending
upon the degree of HDL maturation, apoA1 serves as the fundamental structural element of the particle (16, 17) and is critical for specific interactions with proteins involved in HDL biogenesis (18, 19), maturation and remodeling (20, 21), and
recognition by target organ receptors (22, 23).
Because HDL can be generated in a relatively homogenous
form, most structural studies of HDL have focused on reconstituted nascent HDL, a particle composed of two molecules of
apoA1 associated with phospholipid and free cholesterol (16,
17). Early small angle neutron scattering (SANS) and small
angle x-ray scattering (SAXS) studies of nascent HDL particles
were reported nearly 3 decades ago and are consistent with an
outer protein layer relative to a central lipid core (24, 25). Current structural models of nascent HDL have an anti-parallel
apoA1 chain orientation and posit that the protein exists either
as a circumferential double belt shape around a central bilayer
lipid core comprising phospholipid and free cholesterol (16, 17,
26 –31) or as a superhelical shape wrapping around a predominantly micellar lipid core (32, 33). The anti-parallel organization of apoA1 molecules in nascent HDL is supported by
numerous biophysical investigations including mass spectrometry/cross-linking (34, 35), fluorescence energy resonance
transfer (FRET) (36, 37), and electron spin resonance (ESR)
transfer studies (37).
Spherical HDL (sHDL) particles are a more mature form of
HDL, whereby large accumulations of neutral lipids, predomiJOURNAL OF BIOLOGICAL CHEMISTRY
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the D2O/H2O ratio) to match that of a component within a
complex (e.g. protein, lipid, DNA, or RNA), reducing the scattering intensity observed for that component. SANS with
contrast variation, especially when coupled with selective deuteration of individual components, can facilitate triangulation
of the location of individual components within macromolecular complexes. For example, SANS with contrast variation was
the first method to correctly predict the subunit organization of
eukaryotic chromosomes (55), the structural orientation of
protein and DNA within the nucleosome (56), and the organization of rhodopsin within retinal rod outer segment (57), as
well as to triangulate the location of various proteins and RNA
within the ribosome (58, 59). Herein we use the combination of
contrast variation SANS and selective deuteration of apoA1 to
directly visualize the low resolution structure of the protein and
lipid core components individually within biologically active
reconstituted sHDL. The overall shape observed for apoA1 and
its orientation relative to the central lipid phase of sHDL provides structural insights into how the protein component of
sHDL accommodates the dynamic changes that occur within
the lipid core during particle maturation and remodeling. It
also suggests how apoA1 within sHDL functions as a structural
scaffolding to facilitate lipid transport functions of the particle
during reverse cholesterol transport.

EXPERIMENTAL PROCEDURES
Preparation of Reconstituted Spherical HDL Particles—Human apolipoprotein A1 was purified from plasma from healthy
volunteers as described with modifications. Briefly, HDL was
isolated from fresh human plasma by density centrifugation
from 1.07 to 1.21 g/ml with KBr. Then HDL proteins were precipitated using methanol/chloroform/cold ether sequentially
before resuspension in 20 mM Tris, pH 8.5, 6 M urea. Human
apoA1 in HDL was purified from HDL protein precipitates using
ion-exchange chromatography (Q Sepharose HP HiLoad 26/10
column from GE Healthcare). Human apoA1 was stored in PBS
with 3 M guanidine HCl at ⫺80 °C before use. Deuterated recombinant His-tagged human apoA1 (rh-apoA1) was produced in
Escherichia coli BL21 pLys strain grown in minimal medium as
described previously (27). One liter of the minimal medium
consisted of M9 salts, 0.1% NH4Cl, 10 mM MgCl2䡠6H2O, and 30
mg of thiamine in 99.8% D2O supplemented with trace elements, which included 60 mg of CaCl2䡠2H2O, 60 mg of
FeSO4䡠7H2O, 11.5 mg of MnCl2䡠4H2O, 8 mg of CoCl2䡠6H2O, 7
mg of ZnSO4䡠7H2O, 30 mg of CuCl2䡠2H2O, 0.2 mg of H3BO3,
2.5 mg of (NH4)6Mo7O24䡠4H2O, and 50 mg of EDTA. Bacterial
Cells were first grown in LB medium containing 70% D2O overnight at 37 °C and then harvested by centrifugation at 3000 rpm
for 30 min. Cells were resuspended in minimal medium after
being washed with PBS three times and grown to mid-log
phase. Expression of rh-apoA1 was induced by the addition of
0.4 mM isopropyl 1-thio-␤-D-galactopyranoside. Deuterated
rh-apoA1 was purified to homogeneity by nickel chromatography as described (27).
Reconstituted nascent HDL was prepared by the cholate dialysis method (42). For preparation of deuterated reconstituted
nascent HDL, deuterated rh-apoA1 was used. An initial ratio of
100:10:1, 1-palmitoyl-2-oleoyl-sn-glycero-3 phosphatidylcholVOLUME 286 • NUMBER 14 • APRIL 8, 2011
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nantly cholesteryl esters, are carried as cargo by the particles.
Despite sHDL being the most abundant circulating form of
HDL, relatively few studies have experimentally addressed its
structure in detail because of its size and compositional heterogeneity. Indeed, analytical ultracentrifugation (38), nondenaturing gradient gel electrophoresis (39), immunoaffinity chromatography (40), and two-dimensional electrophoresis (41)
techniques all reveal heterogeneous sHDL preparations containing typically 3 or 4 apoA1/particle. The ability to form
chemically and physically defined reconstituted sHDL by incubating reconstituted nascent HDL with lecithin:cholesterol
acyltransferase, the plasma enzyme responsible for the maturation of nascent HDL into spherical particles (42, 43), has permitted some structural studies into the overall architecture of
apoA1 on the sHDL surface. Early characterization studies
using circular dichroism and fluorescence spectroscopy suggest that the apoA1 in reconstituted nascent HDL and sHDL
have similar ␣-helical content, with sHDL being more resistant
to chaotropic denaturants (42). Further, monoclonal antibody
studies of different apoA1 epitopes suggest that the overall
structure of apoA1 is comparable in reconstituted sHDL and
HDL isolated from human plasma (42). However, differences in
fluorescence emission (36), particle charge (44), proteolytic
sensitivity (45) and 13C NMR studies (46) between reconstituted nascent HDL and sHDL have also been reported, suggesting at a minimum the presence of localized structural changes
of the apoA1 in nascent versus sHDL. Despite these observations, recent protein cross-linking/mass spectrometry-based
studies of reconstituted nascent HDL of various sizes and
monodisperse preparations of sHDL have demonstrated, for
the most part, similar apoA1 interchain cross-links within the
different particles, suggesting that within the resolution limits
of protein cross-linking analysis, apoA1 apparently adopts a
relatively consistent general structural framework in HDL particles irrespective of the shape, size, and number of apoA1 molecules present (47). Thus, whether apoA1 undergoes a global
reorganization during maturation from a nascent to spherical
form remains unknown. Indeed, despite the importance of
HDL to both cholesterol metabolism and cardiovascular disease, the overall conformation of apoA1 within sHDL forms has
not yet been directly visualized. Because of the lack of direct
experimental data on the shape of apoA1 within sHDL, some
investigators have produce computational models by means of
coarse grained molecular dynamics simulations for sHDL particles containing either two (48, 49) or three (50) truncated
apoA1 chains. The relevance of these hypothetical models will
remain unclear until they are more fully tested against structural data for apoA1 in sHDL.
Small angle scattering (SAXS for x-ray and SANS for neutron) is a powerful tool for the investigation of macromolecular
complexes in solution, providing information on their overall
dimensions, morphology, and composition (51–53). SANS
with contrast variation yields low resolution structures, yet is
particularly useful in revealing the organization of a multicomponent system because it combines structural and compositional information that is difficult to obtain by other
approaches (32, 54). During the contrast variation experiment,
the scattering length density of solvent is adjusted (by varying
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ally analyzing the MS/MS spectra. Only sequence-confirmed
cross-links were used.
Compositional Analysis of Reconstituted sHDL—The phospholipid composition of reconstituted spherical HDL was
determined by microphosphorus analysis (27, 32). The amount
of protein in reconstituted spherical HDL was quantified by
stable isotope dilution LC/MS/MS analysis of multiple amino
acids (Phe, Tyr, and Leu) assuming the protein sequence of
human apoA1. Calculated results of protein mass from all three
amino acids agreed within ⫾7%. The free and total (following
KOH saponification) cholesterol concentrations in reconstituted spherical HDL were determined enzymatically using
commercial kits from Stanbio Laboratory and Wako Diagnostics. The amount of cholesterol ester in the sHDL preparations
was calculated by subtracting free cholesterol from total
cholesterol.
Cholesterol Efflux Assay—Cholesterol efflux assays were
performed as described (32). Briefly, cholesterol-loaded
RAW264.7 cells in 24 well plates were loaded with 0.3 Ci/ml
[3H]cholesterol overnight in 1% FBS-DMEM. The next day,
ABCA1 expression was induced with 8-bromo-cAMP in
DMEM supplemented with 50 mM glucose, 2 mM glutamine,
and 0.2% BSA for 16 h at 37 °C. The day after induction, plasma
HDL (5 g/ml protein, final) or reconstituted spherical HDL (5
g/ml apoA-I, final) in 0.5 ml of serum-free DMEM with or
without 8-bromo-cAMP was added to each well. After a 6-h
incubation at 37 °C, the medium was removed and centrifuged,
and 250 l was counted as a measure of cholesterol released
into the medium. The cells were extracted with hexane/isopropanol (3:2), and radioactivity was counted as a measure of cholesterol retained within the cell. The percent cholesterol efflux
was calculated as the radioactivity in the medium/total radioactivity (medium radioactivity plus cell radioactivity). The control was performed using the same procedure without the addition of sHDL.
SR-B1-specific Binding of Spherical HDL—Spherical HDL
made with bacterial ApoA1 was iodinated using the iodine
monochloride method as described by Brown and colleagues
(61). 293-T cells were transfected with vector or SR-B1 using
Lipofectamine 2000 according to the manufacturer’s instructions. Binding of the radiolabeled reconstituted spherical HDL
to SR-B1 was determined by incubating 125I-labeled sHDL with
either vector-transfected or SR-B1-transfected cells for 1.5 h at
4 °C (32). The cells were washed twice with 250 mM NaCl, 25
mM Tris, pH 7.4, and once with 250 mM NaCl, 25 mM Tris, pH
7.4, containing 2 mg/ml BSA and then solubilized in 1 ml of
0.1 M NaOH at room temperature for 20 min. Cell-associated
radioactivity was subsequently determined with a Gamma 4000
spectrometer (Beckman Coulter). Specific binding was calculated as total binding minus binding in the presence of a 20-fold
excess of unlabeled sHDL.
SANS Experiments—Small angle neutron scattering experiments were performed on sHDL samples prepared as described
above. SANS data were collected at a controlled temperature
(6 – 8 °C) both on the beamline D22 in Grenoble, France, and on
KWS-2, the outstation of the Forschungszentrum Juelich at
FRMII in Munich, Germany. All experiments showed consistent results on multiple preparations. Following analysis, the
JOURNAL OF BIOLOGICAL CHEMISTRY
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ine:cholesterol:apoA1 (mol:mol:mol) was used to generate the
reconstituted nascent HDL followed by gel filtration chromatography as described previously (27). Reconstituted spherical
HDL was prepared by incubating either deuterated or nondeuterated nascent HDL with isolated human lecithin:cholesterol
acyltransferase and isolated human LDL at 37 °C for 24 h (42).
Reconstituted spherical HDL was then isolated by sequential
ultracentrifugation in the 1.07 ⬍ d ⬍ 1.21 g/ml density range
and further purified by gel filtration chromatography on a Sephacryl S-300 column.
Chemical Cross-linking and Mass Spectrometric Analyses—
Chemical cross-linking and mass spectrometric analyses were
performed to determine the stoichiometry of apoA1 on spherical HDL. Briefly, bis(sulfosuccinimidyl)suberate (BS3; from
Pierce) was dissolved in PBS at a concentration of 8 mg/ml
added to reconstituted spherical HDL (0.4 mg/ml apoA1) at a
200:1 molar ratio (BS3 versus apoA1) and incubated for 5 min at
37 °C. The reaction was immediately quenched by the addition
of 1 M Tris buffer to a final concentration of 100 mM at pH 7.4.
To estimate the number of BS3 mol adducted to apoA1, the
content of derivatizable lysine residues remaining on crosslinked delipidated apoA1 was assayed using the sensitive fluorogenic o-phthaldialdehyde reagent and purified apoA1 as the
standard (60). The mass of delipidated cross-linked apoA1 from
sHDL was measured directly using MALDI-TOF mass spectrometry. Sinapic acid prepared in 50% acetonitrile with 0.1%
TFA was mixed with cross-linked apoA1 (1:1 by volume), and ⬃
0.75 l of the mixture was spotted on a stainless MALDI plate.
The spectra were acquired in the positive linear mode on an
ABI 4800 proteomics analyzer mass spectrometer. Each spectrum was generated by averaging 3000 laser shots with the laser
intensity at 5000. External calibration was performed using
bovine serum albumin and monoclonal antibody against IB
kinase as calibrates.
ApoA1 cross-linking within spherical HDL was performed as
described (47). Briefly, sHDL (0.5 g/l) in PBS, pH 7.4, was
incubated with BS3 (10:1 molar ratio) at 4 °C for 24 h. During
the first hour the solution was mixed gently every 15 min. The
cross-linking reaction was terminated by the addition of Tris
HCl at a final concentration of 100 mM and then stored at
⫺80 °C prior to analysis. Cross-linked monomer, dimer, and
trimer forms of apoA1 within sHDL were separated on a 12%
SDS-PAGE before being transeluted into a 14-channel fraction
collector using a mini whole-gel eluter apparatus (Bio-Rad).
The fractions containing monomer, dimer, and trimer apoA1
(confirmed by MALDI-TOF analysis as described above) were
dialyzed against 20 mM NH4HCO3 and then digested with tryspin (Promega, Madison, WI) at a ratio of 500:1 (w/w). The tryptic digests were separated on a C18 nano column (75 mm ⫻ 10
cm, Proxeon) using an EASY-nLC system interfaced with LTQ
MS (Thermo Scientific) at a flow rate of 300 nl/min and a gradient of 5–35% acetonitrile in 0.1% formic acid for 45 min. The
mass spectra were acquired in a data-dependent mode with a
mass scan range of 300 to 2000 daltons. The candidates for
cross-linked peptides were searched by inputting masses of
peptide list into a Web-based search program, and then the
sequences of cross-linked peptides were confirmed by manu-
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I corr共q兲 ⬇ Icorr共0兲 exp共⫺Rg2q2/3兲

(Eq. 1)

The molecular weight calculation of apoA1 was based on Equation 2 using the Icorr(0) of the scattering curve.
I corr共0兲/c ⫽ 10⫺3/NA共NA⌺b ⫺ 0V/M兲2M

(Eq. 2)

The factor 10⫺3 is required to express protein concentration (c)
in the usual way as mg/ml, NA is Avogadro’s number, the term
in parentheses is the excess scattering length sum of protein
atoms calculated from its composition, 0 is scattering length
density of the solvent, V is protein or lipid volume calculated
from its partial specific volume, and M is the molar mass in
g/mol (63).
Low Resolution Structure Determination—Low resolution
structures of protein and lipid components were generated
from their respective corrected intensities, Icorr, by using the
program DAMMIN (64). The corrected sample intensities were
first fitted in the specified q ranges (protein component, 0.007–
0.35 Å⫺1; lipid component, 0.007– 0.24 Å⫺1) by using the program GNOM (65). GNOM (which uses indirect Fourier transformation (66)) reads one-dimensional experimental scattering
intensities (considering errors) and evaluates a distance distribution function p(R). Then the program DAMMIN produces
low resolution structures (with maximal extension Dmax) by
using the p(R) function. The final structure obtained is consistent with the experimental data. Two qualitative criteria for
these fits were checked for each contrast level: 1) a smooth
behavior of p(R) and 2) a good agreement between the radii of
gyration (Rg) calculated by GNOM and determined by the
Guinier approximation (Equation 1). All samples of different
contrast level fulfilled these criteria in a satisfactory manner.
The output of the GNOM program was used as input data
for the program DAMMIN to build the low resolution structures. The DAMMIN default parameters were used for the
modeling process. The final models of the protein and lipid
components are the average of at least 10 outputs of the program DAMMIN using the program DAMAVER (64). The low
resolution structure obtained from the 12% D2O scattering
intensities (protein component of sHDL) was used to build the
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first schematic model of the protein architecture. This model
was further optimized by improving the goodness of fit of the
calculated scattering intensities versus the experimental data.
This was achieved by gradually adjusting the shape of the three
apoA1 chains in the model and comparing the calculated scattering intensities with those obtained experimentally.
High Resolution Models—To identify possible arrangements
and plausible conformations of the three chains of ApoA1 that
can fill the SANS shape of the protein component of sHDL,
initially we built straight-line three-dimensional tube-like
models made to match the length of a full ApoA1 chain. Next,
we bent the tubes to follow the shape of the SANS low resolution structure of the protein and created three different combinations designated (below) as the helical-dimer-hairpin
(HdHp), three-hairpin (3Hp), and integrated trimer (iT) models. Then, using these tube-like models we constructed all-atom
models of the three possible topologies of the apoA1 trimer
(HdHp, 3Hp, and iT). The all-atom models followed accurately
the same conformation of the individual chains found in their
tube-like counterparts. The apoA1 chains, modeled in an all-␣helix conformation, were oriented with the hydrophobic face of
the amphipathic ␣-helix toward the lipid core and the hydrophilic face toward the outside, similar to the orientation of the
amino acid residues found in previous models of nascent HDL
(26, 32). These models are very crude, and their geometry was
not optimized. That is, energy minimizations or molecular
dynamics simulations were not performed either in gas phase
or in solution. Thus, these models do not contain accurate
information about the solvent accessibility of individual residues. The all-atom models of the ApoA1 trimer were built for
the purpose of performing the SANS and cross-link analyses
presented below and in supplemental Table 1. We calculated
the scattering intensity given off by the all-atom models and
the goodness of fit with the experimental scattering data
listed in Table 1 using the program CRYSON (67). For the
cross-link analysis we performed free rotations of lysine residues within 25 Å of each other for all models. The distances
between lysine residues found to be involved in cross-links
were measured between the nitrogen atoms of the side
chains of the two residues. These distances are listed in supplemental Table 1.3

RESULTS AND DISCUSSION
Chemical, Biochemical, and Biological Activity Characterization of Reconstituted sHDL—Monodisperse and relatively
homogeneous preparations of reconstituted sHDL were prepared using the methods initially reported by Rye et al. (43).
Preparations of nondeuterated and deuterated sHDL were generated from reconstituted nascent HDL produced with either
human apoA1 or deuterated recombinant human apoA1 as
outlined under “Experimental Procedures.” Following the final
isolation step of gel filtration chromatography, the sHDL preparations were initially characterized by native nondenaturing
3

Information on neutron scattering intensities for spherical HDL samples
analyzed in 12 and 42% D2O (text files) and low resolution structures of the
protein and lipid components of spherical HDL (Protein Data Bank files) is
available by contacting the corresponding author (S. L. Hazen).
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samples were recovered and used for chemical, biochemical,
and biological assays. Scattering data were obtained as a function of the scattering angle and corrected by subtraction of
incoherent scattering and empty cell before being averaged
radially and calibrated in absolute units. All samples and buffers
were recorded with neutron beams of  ⫽ 4.5 or 7 Å. The
scattering neutron density was determined as the macroscopic
cross-section I(q) in units of cm⫺1 versus the momentum transfer q ⫽ (4/)sin, where 2 is the scattering angle. To cover a
wide range of q and to ensure good merging statistics, the
scattering experiments were performed at 2, 4, and 7 m
detector-to-sample distances covering a range of 0.007 ⬍
q ⬍ 0.45. The buffer was subtracted from the scattering
curve, and the resulting scattering curves were processed
using the program PRIMUS (62). The experimental radii of
gyration of scattering contrast, Rg, of the samples were calculated from the Guinier range (Rgq)2 ⬃ 1 of the scattering
curve (Equation 1).
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sHDL scattering intensity data from 12% D2O solution and the
superimposed calculated scattering curve for the low resolution
structure. The maximum value of the scattering vector (q) is
0.44 Å⫺1, which corresponds to a resolution in real space of 14.5
Å. The middle panel of Fig. 1A shows the distance distribution
function, p(R), which is used to construct the low resolution
structure of the protein component of sHDL (Fig. 1A, right
panel). To determine the low resolution structure of the lipid
component of sHDL, particles reconstituted with nondeuterated apoA1 were measured at 42% D2O contrast level, the
matching point of the protein component of sHDL. Fig. 1B
shows the experimental data (left panel) and the calculated
scattering curve obtained from the low resolution shape
envelop of the lipid (right panel). The p(R) function of the lipid
component is shown in Fig. 1B, middle panel. Finally, the
Stuhrmann plot (68) (where the square of Rg is plotted against
the inverse of the difference between the matching point of the
whole molecule (18% D2O) and each contrast level) produces a
straight-line, with a positive slope (Fig. 1C), indicating two
structural features: (i) the centers of gravity of the protein and
lipid components within sHDL coincide; and (ii) the component with higher scattering length density (protein) is located at
the periphery of the particle. Goodness-of-fit (2) analyses for
the predicted scattering curves from the low resolution SANS
structures of the protein and lipid components of sHDL versus
the experimental scattering intensities show excellent agreement for both the protein and lipid components. Overlapping
views of the low resolution structures of the protein and lipid
components of reconstituted sHDL in two different orientations are shown in Fig. 1C (right). The shape of the combined
protein and lipid structures is spheroidal. It is evident from the
superposition that the overall architecture of the protein component of sHDL is a hollow structure (orange beads) that cradles the nonspherical compact lipid core (green beads), and the
lipid component located inside the particle is only partially surrounded by the outer protein wrapper (Fig. 1C, middle and
right).
Proposed Possible Global Arrangements of ApoA1 Chains in
sHDL—In contrast with nascent HDL, the structure of which
has been extensively investigated, there are relatively few
experimental studies on sHDL structure to date (29, 47).
Only one of the recent studies has obtained geometrical constrains among apoA1 molecules within sHDL particles using
cross-linking (47), and the other produced only EM images
of an entire particle (29). Of note, no studies to date directly
visualize the shape of apoA1 in sHDL in sufficient detail to
determine the overall architecture of protein within the
spherical particle.
Recent mass spectrometry studies by Silva et al. (47) report
that cross-links in reconstituted sHDL preparations are for the
most part the same as those observed in nascent HDL. However, among the cross-links identified, seven were observed
only in reconstituted sHDL (supplemental Table 1) and not in
nascent HDL preparations. In that study, several hypothetical
arrangements of three apoA1 molecules were proposed to
explain the cross-links identified within sHDL. The first
arrangement posited was a planar circular belt consisting of
three apoA1 molecules, all in an anti-parallel orientation. In the
JOURNAL OF BIOLOGICAL CHEMISTRY
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gradient gel electrophoresis and dynamic light scattering to
confirm the relative homogeneity of the preparation. More
extensive characterization studies, including those shown in
supplemental Fig. 1, were then repeated on samples recovered
following SANS analyses to ensure that the properties of the
particles did not change during the course of the experiment.
sHDL particle preparations studied by SANS and cross-linking/
mass spectrometry were initially characterized to confirm
homogeneous monodisperse particles with composition and
biological activity similar to sHDL isolated from human
plasma (supplemental Fig. 1). Reconstituted sHDL particle
preparations containing either human plasma-derived
apoA1 (h-sHDL) or deuterated recombinant apoA1 (d-sHDL)
were each shown to have a hydrodynamic diameter of ⬃93 Å as
monitored by equilibrium native nondenaturing gradient gel
electrophoresis (supplemental Fig. 1, A and C). Chemical compositional analyses of both nondeuterated and deuterated
sHDL preparations showed similar lipid composition (phospholipid/free cholesterol/cholesterol ester) and apoA1 content
(supplemental Fig. 1B), and cross-linking studies and SDSPAGE analysis suggested 3 molecules of apoA1/sHDL particle
(supplemental Fig. 1D). This result was further confirmed by
independent MALDI-TOF mass spectrometry analyses of
delipidated cross-linked apoA1 recovered from sHDL, with the
bulk of the protein detected possessing mass close (within
⬃0.2% predicted) to that anticipated for a trimeric apoA1 particle plus the estimated added mass provided from cross-linking/quenching agents (supplemental Fig. 1E). Analyses of the
biological activity of the sHDL preparations used for SANS
showed cholesterol efflux activity when incubated with cholesterol loaded macrophages similar to that observed with a common spherical HDL (HDL3) isolated from human plasma (supplemental Fig. 1F), and sHDL preparations showed saturable
and specific binding to the HDL receptor, scavenger receptor
B1 (supplemental Fig. 1G). Collectively, these results demonstrate that the reconstituted sHDL particles studied by SANS
and cross-linking/mass spectrometry in the present studies
have a chemical composition, overall stoichiometry, particle
size, and biological activity similar to HDL3 isolated from
human plasma, and appear to be both monodisperse and
homogeneous.
SANS Analyses of sHDL Are Consistent with a Peripheral Trimeric ApoA1 That Cradles an Inner Spheroidal Compact Lipid
Core—SANS experiments were performed at multiple levels of
contrast on sHDL preparations generated using either nondeuterated or deuterated apoA1 (Fig. 1). Samples demonstrated
monodisperse characteristics, without detectable traces of
aggregation. The molecular weight of the protein within sHDL
measured by SANS was consistent with a trimer (8.1– 8.6 ⫻ 104
atomic mass units). The radius of gyration (Rg) at each contrast
level and the overall particle dimensions are listed in Table 1.
SANS with contrast variation studies permitted the determination of the individual low resolution structures of the protein
and lipid components of sHDL. The scattering signal of the
sHDL protein component was enhanced through the incorporation of deuterated apoA1 into the reconstituted sHDL preparations and measurement at the average matching point of the
lipid (12% D2O). Fig. 1A, left panel, shows the experimental
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FIGURE 1. Small angle neutron scattering results. A, neutron scattering results for sHDL in 12% D2O. Left panel, the scattering intensity as a function of the
scattering vector q. The experimental data are plotted with open circles and have error bars attached. The experimental scattering curve displays oscillations
with maxima at ⬃0.1, 0.2, and 0.25 Å⫺1. The solid orange line is the scattering intensity calculated from the low resolution structure obtained by deconvoluting
the experimental data. Middle panel, the distance distribution function, p(R), plotted as a function of the distance between scattering centers. The p(R) value was
obtained by deconvoluting the experimental scattering intensities of sHDL in 12% D2O with the program GNOM. Right panel, low resolution structure of the
protein component of sHDL obtained from the p(R) function (middle panel) with the program DAMMIN. B, neutron scattering results for sHDL in 42% D2O. Left
panel, the scattering intensity (open circles) for sHDL in 42% D2O. The error bars are very small and only slightly visible at the center of the open circles. The solid
green line is the scattering intensity produced by the low resolution structure of the lipid. Middle panel, the p(R) function for the lipid component of sHDL. Right
panel, low resolution structure of the lipid component of sHDL obtained from the p(R) function (middle panel). C, left panel, the Stuhrmann plot gives the
dependence of Rg2 (where Rg is radius of gyration) on the contrast level (X) in the SANS experiment. A linear graph (red line) indicates that the protein
component is located on the outside, and the lipid component is inside as shown by the overlap of the low resolutions structures for the 12% D2O (orange) and
42% D2O (green) in the middle and right panels. X, Y, and Z represent the directions of the Cartesian coordinate system.

second arrangement, one apoA1 was hypothesized to exist as a
hairpin and the other two apoA1 molecules were arranged in a
planar circular anti-parallel double belt configuration. In a third
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arrangement, the three apoA1 molecules were hypothesized to
be associated in a clever symmetrical structure retaining the
anti-parallel apoA1 chain orientation forming a “trefoil” (47).
VOLUME 286 • NUMBER 14 • APRIL 8, 2011
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TABLE 1
Radius of gyration, dimensions, and goodness of fit for the low resolution SANS structures of spherical reconstituted HDL
Rg
sHDL % Experimental Low resolution
D2O
curve
structure
Å

0
12
42
90

39.1 ⫾ 0.43
47.3 ⫾ 0.08
31.0 ⫾ 0.03
34.8 ⫾ 0.49

Å

45.2
30.9

2

Length:Width:Height
Å

1.483 111:96.6:88.7
2.887 88.4:68.2:60.3
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The highly symmetric protein models proposed for the three
apoA1 molecules based on cross-linking studies (47) clearly do
not fit the experimental SANS shape visualized for the protein
component of sHDL. However, combining SANS studies with
contrast variation and complementary structural information
from alternative biophysical approaches such as cross-linking/
mass spectrometry data can provide synergistic information
that, when considered in combination, imposes considerable
constraints on the possible permutations through which the
apoA1 may be oriented within sHDL. We note that the SANS
resolution for the protein component of sHDL (14 Å) is sufficient to resolve the location of the apoA1 chains within the low
resolution structure of sHDL, because the average distance
between two apoA1 chains (outer residues) in a belt configuration is about 14 Å. Thus, the low resolution structure of the
protein within sHDL visualized by SANS creates a puzzle as to
how to arrange three apoA1 molecules within the protein
envelop while still accounting for the biophysical attributes
reported in prior studies of sHDL preparations. Following other
investigators (e.g. Silva et al. (47)) we produced computer-generated three-dimensional schematic models that have all-atom
representation, which makes them suitable for distance analysis. We do not claim that these schematics give detailed information about the relative orientation of amino acid residues in
apoA1 within sHDL; but we believe that taking into account the
spatial constraints imposed by the primary and secondary
structure of apoA1 in combination with its low resolution
structure resolved by SANS, the schematic model of the protein
is a fair description of the overall architecture of the apoA1
trimer in sHDL and thus is appropriate for the MS cross-linking
analysis. In this spirit, all protein structures considered
included maximal retention of a predominantly anti-parallel
orientation for the apoA1 chains in 5/5 helix registry, a necessity given the previously observed crystal structure of the lipidfree truncated mutant (residues 44 –243, exon 4) apoA1 (69)
and the large numbers of reported FRET, ESR, and cross-link
studies of HDL (17, 27, 35, 47, 70 –72).
Although it is not immediately recognizable how individual
chains of apoA1 might be oriented within the protein low resolution structure, given the length of an apoA1 polypeptide
chain, further analyses suggest only a handful of possible global
categories of apoA1 configurations that can fit within the structural confines dictated by the protein shape envelop. Fig. 2
shows three general categories of possible arrangements of the
apoA1 trimer superimposed on the protein envelop determined by SANS while simultaneously maintaining apoA1 chain
anti-parallel orientation. In Fig. 2A the three protein chains
(colored red, blue, and green) are arranged as a combination of

a helical dimer and a folded-back hairpin. We call this arrangement the “helical-dimer-hairpin” model. The HdHp model for
the apoA1 trimer predicts that the apoA1 hairpin folds back,
bringing its N terminus close to its helix 5 (h5) domain. Other
predicted distinct features are the specific contacts/interactions of the hairpin with the dimer and the fact that the hairpin
h5 domain is not aligned with the dimer h5 domains. Another
possible global arrangement of the apoA1 trimer within the
protein envelope is shown in Fig. 2B as three distinct apoA1
hairpins. Although multiple configurations of this global
arrangement are possible, we chose to orient two hairpins (red
and blue (Fig. 2B)) such that they interact through their h5
domains (given the cross-linking data for apoA1 in sHDL; see
below), whereas the third hairpin (green) has the same orientation as in the HdHp structure in Fig. 2A. This model is called the
“three-hairpin” model, because the apoA1 dimer is replaced by
two apoA1 monomers that occupy the same volume of the
SANS envelope. Further, it can be expected that cross-links that
have been reported to discriminate between a double belt
model versus the hairpin models for apoA1 of nascent HDL (34,
37, 73) will also discriminate between models HdHp and 3Hp.
Finally, we explored the possibility of a third global arrangement whereby the model topologically resembles in part the
trefoil model (47), because all three apoA1 monomers associate mutually over a portion of their protein chains. Because the
protein envelop visualized by SANS does not share the same
symmetry properties with the trefoil model, we call the apoA1
trimeric model that somewhat simulates the trefoil model yet
fits within the SANS shape the “integrated trimer” model (Fig.
2C; note that the iT model has only one node instead of two
where all three apoA1 chains join together, and the actual conformation of the individual apoA1 chains is very different from
that in the trefoil model). In the trefoil model all apoA1 monomers are aligned with their h5 domains (47).
Table 2 shows the goodness of fit for each of the hypothetical
orientations of apoA1 posited versus the actual experimental
SANS data. We used the three-dimensional tube representations shown in Fig. 2 for each model to generate an all-atom
model for the protein that was made mostly of a continuous
␣-helical ribbon. These models do not contain information
about the solvent accessibility of individual amino acids, but the
orientation of the amino acid residues was consistent with that
found in previous models of nascent HDL whereby hydrophobic ␣-helical surfaces are oriented toward the lipid core and
predominantly hydrophilic ␣-helical apoA1 side chains are oriented toward the aqueous phase (26). The scattering intensities
at various scattering angles are shown in Fig. 3A (blue line) for
the HdHp model superimposed on the experimental data (open
black circles); also shown is the calculated scattering curve corresponding to the low resolution SANS structure (solid orange
line). The agreement among all three curves is excellent, as
indicated by the goodness of fit (calculated 2 ⫽ 1.192 and
1.483, respectively (Tables 1 and 2)).
A comparison of the goodness of fit of the calculated scattering curves from each of the three global models of apoA1 architecture (HdHp, 3Hp, and iT) versus the actual experimental
SANS scattering data reveals that the HdHp and 3Hp models
most closely fit the experimental data, whereas the iT model fits
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FIGURE 2. Possible architectures of the apoA1 trimer in spherical HDL. A, superposition of the 12% D2O low resolution structure of sHDL (orange) with a
schematic representation of the apoA1 trimer made of a helical dimer (red/blue) and a hairpin (green): the HdHp model. The three chains are gradient-colored
(dark N terminus and lighter colored C terminus). The three panels depict different orientations of the HdHp model. B, the architecture of the apoA1 trimer
corresponds to three hairpins that fit the 12% D2O low resolution shape: the 3Hp model. The red and blue hairpins interact with their helix 5 domains. The green
hairpin retains the same orientation as the one in A. C, in this architecture (iT model) the apoA1 trimer has each chain associated with each other one, producing
three dimers. All chains interact together with their helix 5 domains.

TABLE 2
Radius of gyration, goodness of fit of geometrical constraints, and
number of predicted cross-links for the molecular models of apoA1
trimer in spherical reconstituted HDL
Model

Rg

2

Satisfied cross-linksa

Å

HdHp
3Hp
iT
a

45.6
45.6
45.8

1.192
1.183
1.515

23
19
21

Of 23 reported by Silva et al. (47).
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less well (Table 2). The all-atom structure for the HdHp model
is shown in Fig. 3B superimposed with the low resolution structure of the protein (semitransparent orange beads). Fig. 3C
shows the all-atom model HdHp in three different orientations
that emphasize the helical conformation of the dimer, and Fig.
3D shows how the all-atom model of the protein wraps around
the low resolution structure of the lipid core (semitransparent
green beads). The SANS analysis of the three possible overall
architectures of the apoA1 trimer in sHDL cannot on its own
discriminate between the three global models, but it can select
VOLUME 286 • NUMBER 14 • APRIL 8, 2011
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FIGURE 3. Comparison of experimental neutron scattering intensities with those obtained from the low resolution structure and the molecular model of the
apoA1 trimer. A, the fit of scattering intensities produced by the 12% D2O low resolution structure (orange curve) and the molecular model (blue curve) of the apoA1
trimer (HdHp model) to the experimental data. B, the superposition of the molecular model of the apoA1 trimer (HdHp) with the 12% D2O low resolution structure
(semitransparent orange beads). The molecular model of the apoA1 trimer is shown as three chains, two of them in a helical dimer conformation, and the third chain
forms a hairpin. Because the molecular model does not include any local information about the conformation of the individual amino acid residues, the secondary
structure of the chains was assigned to be ␣-helix for all residues. The three chains are gradient-colored red, blue and cyan. C and D, superposition of the HdHp model
with the low resolution structure (orange) of the protein component (12% D2O) of sHDL (C) and the low resolution structure of the lipid component (42% D2O) (D).

specific conformations of apoA1 that fit the low resolution
structure of sHDL. Consequently, the subset of possible conformations can be further analyzed for compliance with geometrical constraints derived from cross-linking studies, and the
combined analysis can thus be used to identify the most probable architectures of the apoA1 trimer that satisfy all arrays of
biophysical constraints revealed thus far.
Geometrical Constraints Analysis of ApoA1 Chain Crosslinking Data Coupled with SANS Discriminates among the
Overall Architectures Posited for ApoA1 in sHDL—The construction of crude all-atom models (HdHp, 3Hp, and iT) for the
APRIL 8, 2011 • VOLUME 286 • NUMBER 14

apoA1 trimer allowed us to perform a geometry constraints
analysis of the apoA1 chains by comparing the experimentally
reported cross-links for sHDL (35, 47) and those newly determined in our sHDL preparations with those predicted by the
models. A summary of this comparison is given in Table 2 and
a more detailed description in supplemental Table 1, which lists
the individual cross-links identified in our sHDL preparation
(93 Å particle, S93) and those predicted by the three proposed
architectures of apoA1 trimer in sHDL (i.e. the HdHp, 3Hp, and
iT models). Recently, Silva et al. (47) identified 23 cross-links in
sHDL particles of 93 Å in diameter (S93) that contain three
JOURNAL OF BIOLOGICAL CHEMISTRY
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the data in supplemental Table 1 shows that the 3Hp model can
be ruled out as a possible architecture of the apoA1 trimer, as it
cannot accommodate most of the interchain cross-links
because of its specific topology (all three apoA1 chains selfassociate, and only few interchain cross-links would be predicted). As a consequence, four interchain cross-links (Lys40–
Lys239, Lys118–Lys140, Lys59–Lys208, and Lys77–Lys195) are not
accommodated by this model. On the other hand, the iT model
has all three chains associated with each other and thus does
not accommodate some of the intrachain cross-links (Lys12–
Lys94 and N-terminal Lys106) seen in the HdHp model. Taken
together, the combined SANS and MS/cross-link data point to
the HdHp model as the most plausible global topology of apoA1
within sHDL.
Comparison of Currently Visualized SANS Shape of ApoA1
within sHDL versus Prior Reported Models Obtained by Molecular Dynamics Simulation and Electron Microscopy Studies—
In the absence of direct structural data for the overall shape of
protein within sHDL, other investigators have attempted to
construct purely theoretical models of the particle by computer
simulations. It therefore may be of interest to compare the low
resolution (⬃14 Å) shape envelop of the protein component
within reconstituted sHDL, as visualized by SANS in the present study, with the previous hypothetical models obtained by
simulation. Three molecular dynamics simulations of sHDL
have been reported to date (48 –50). Despite the fact that sHDL
typically contains three or more apoA1 chains, these computational models focus predominantly on simulations of sHDL
with only two apoA1 chains (48 –50). In general, the molecular
dynamics simulation studies of sHDL start with the protein in a
discoidal belt organization at the beginning of the simulation,
suggesting that the overall belt shape of apoA1 becomes more
disordered and contorted, with pronounced “kinks” or zigzags
in an out-of-plane conformation (48, 49). The protein conformations in the simulations reported are at marked contrast to
the SANS shape observed in the present investigation. It should
also be noted that prior simulation models of sHDL are also
reported to be at marked variance (49) with the three apoA1containing trefoil structure suggested by Silva et al. (47). It
seems likely that one of the major reasons that marked differences exist between the experimentally observed SANS shape
(which contains three apoA1 chains) is that only two apoA1
chains are used in the molecular dynamics simulations. It is also
worth noting, however, that all simulations and the SANS
shapes directly visualized have some similarities. At a very gross
level, the topological organization of protein within the particle
toward the exterior and a neutral lipid core interior are clear
similarities. It is interesting to note that the simulations of an
sHDL particle suggest that the N- and C-terminal helices of the
apoA1 chains are more flexible and mobile than the central
region of the apoA1 chains (49), a finding consistent with the
conformational alterations we proposed for apoA1 within a
maturing nascent HDL particle to form sHDL (see discussion
below and Fig. 4A, top).
During the course of reviewing this manuscript, Zhang et al.
(29) published a methodology paper for optimized negative
staining electron microscopy (EM) of multiple lipoprotein
particles, including some sHDL preparations. Although both
VOLUME 286 • NUMBER 14 • APRIL 8, 2011
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apoA1 chains. Interchain and intrachain designations for crosslinks observed in tryptic digests of cross-linked S93 by Silva et
al. (47) were based upon results observed previously with nascent HDL (which contains two apoA1) and a smaller more
compact trimeric sHDL form. Thus, cross-linked monomer
versus multimeric apoA1 forms were not separated prior to
mass spectrometry analysis within S93 sHDL by Silva et al.
(47).4 Among the 23 cross-links identified in S93 by Silva et al.
(47), 14 were designated as intrachain and 7 as interchain crosslinks. Two cross-links were not assigned as either intra- or
interchain. We performed similar mass spectrometry/crosslinking analyses of sHDL (S93) preparations but added the step
of electroeluting various cross-linked apoA1 bands from sHDL
preparations (monomer versus dimer versus trimeric forms
confirmed by both SDS-PAGE and MALDI-TOF mass spectrometry (“Experimental Procedures”) as well as performing
in-solution tryptic digestion/MS analyses on the isolated crosslinked proteins. This allowed for direct assignment of detected
cross-links as either intra- or interchain cross-links within
sHDL (supplemental Table 1). It is remarkable that all three
all-atom models for the apoA1 trimer in sHDL preparations
satisfy the majority of identified cross-links, although the HdHp
model appears superior to both the 3Hp and the iT models. For
example, the HdHp model satisfies 23 cross-links, the 3Hp
model satisfies 19, and the iT model satisfies 21 (Table 2). None
of the models satisfies the cross-link Lys208–Lys208 identified by
the same group in a 96 Å nascent HDL particle (47) but not
predicted by any of the proposed nascent HDL models (e.g. the
double belt, the hairpin, the solar flares, and the double super
helix models) unless it arises from a particle-particle interaction (27, 32). The previously reported intermolecular crosslink, Lys182–Lys238, was suggested to perhaps represent apoA1
monomers that had undergone a shift from a 5/5 to a 5/2 helix
registry (47). All protein models proposed here contain this
cross-link in a 5/5 registry, but we predict that it is intrachain.
An intrachain designation for this cross-link is in agreement
with cross-link MS analyses of electroeluted apoA1 forms
examined in the present study (supplemental Table 1). The two
cross-links observed by Silva et al. (47) in sHDL that were not
assigned as either intra- or interchain (Lys182–Lys239 and
N-terminal Lys118) were assigned in this study as inter- and
intrachain cross-links, respectively, on the basis of cross-link
MS analyses of electroeluted proteins (supplemental Table 1).
In the molecular models, Lys182–Lys239 is readily accommodated as an intrachain cross-link, and interchain distances as
small as 40 Å are noted, suggesting that an interchain cross-link
is also plausible based on the models. The distance corresponding to N-terminal Lys118 in all models was ⬍30 Å for both the
intra- and interchain distances in all models (supplemental
Table 1).
Although it is remarkable that all three all-atom models for
the apoA1 trimer in sHDL preparations satisfy the majority of
identified cross-links, there are still significant differences in
the cross-links predicted by the models that make the HdHp
model appear superior. For example, a more detailed analysis of
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FIGURE 4. Hypothetical mechanism of conformational change of apoA1 in nascent HDL during maturation into spherical HDL. A, left, superposition of
the low resolution structures of protein (orange) and lipid (green) components of nascent HDL (top) and one particular orientation of the double super helix
model of the protein component in nascent HDL (bottom left). The two apoA1 chains are gradient-colored red and blue, and the putative lecithin:cholesterol
acyltransferase-binding loops (solar flares) are colored yellow. Middle, overlap of the middle domains of nascent HDL and sHDL apoA1 dimers. The overlapping
suggests how the N and C termini of the apoA1 dimer in nascent HDL might swing and rearrange during particle maturation into what is found to be the dimer
conformation in sHDL. The gray region at the middle of the particle represents the growing core of neutral lipids that accumulate during maturation. Right,
superposition of the low resolution structures of protein (orange) and lipid (green) components of spherical HDL (top), and the resultant architecture of apoA1
trimer in spherical HDL (HdHp model, bottom right). B, hypothetical mechanism for apoA1 inter-exchange in sHDL. The hairpin and the apoA1 dimer are shown in
different conformations that match the low resolution structure (12% D2O) of the protein. The different configurations suggest that it is reasonable to expect that
because of particle dynamics the hairpin can bend such that it aligns its h5 domain with the h5 domain of the dimer (dotted double arrow lines) as a preamble for
annealing with the dimer. Thus, the hairpin can exchange with one of the apoA1 monomers of the dimer through a transient integrated trimer-like configuration
(center), generating other arrangements of the helical dimer/hairpin combination (solid double arrow lines). This protein reorganization mechanism makes all apoA1
monomers equivalent from an exchange point of view and can, in principle, lead to the integrated trimer (iT model) as illustrated on the right.
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Similarly, cross-linking studies point toward the N terminus
of apoA1 within sHDL folding back and coming in closer
proximity to the central region of the apoA1 polypeptide
chain (supplemental Table 1).
ApoA1 is an exchangeable apolipoprotein (75, 76) and can
convert between lipid-poor and lipid-associated states (77,
78). The exchangeability of ApoA1 and its predilection for
forming both highly dynamic amphipathic ␣-helices and salt
bridges seem to be imprinted in its chemical composition
(32, 33). A hypothetical mechanism for apoA1 inter-exchangeability on the surface of the sHDL particle is suggested by the present studies. Although this mechanism may
be important for sHDL remodeling in plasma at body temperature, the rate of apoA1 exchange should be much lower
during the SANS experiment in which samples have been
analyzed at 8 °C. For example, assuming that the activation
energy barrier for exchange is about 20 kcal/mol, the rate
constant at 8 °C is about 30 times smaller than at 37 °C. Fig.
4B is a schematic showing a hypothetical mechanism of how
each of the apoA1 of sHDL may be inter-exchangeable
through a transient rearrangement of apoA1 conformations
posited between the global architectures in the HdHp and iT
models. It is conceivable that an apoA1 hairpin chain, following modest rearrangement (Fig. 4B, left), may begin
annealing into the apoA1 dimer of HdHp forming a threeway node around the helix 5 domain. This annealing process
might be driven by concomitant salt bridge breakage (from
intrachain) and formation (in interchain) of the annealing
apoA1 monomer while simultaneously the dimer gradually
unzips at one end to permit association leading to a transient
integrated trimer-like form (Fig. 4B, center). This intermediate configuration may then rearrange into another dimer/
hairpin combination (Fig. 4B, right) by a reversal of the
annealing process. This mechanism would make it possible
for apoA1 chains in the dimer to exchange partners by incorporating the hairpin, thus making all apoA1 polypeptide
chains interchangeable on the surface of sHDL. We hypothesize that breakage and formation of a large number of salt
bridges within the apoA1 dimer and hairpin may serve as a
primary driving force behind the annealing of the dimerhairpin and dissolution of the annealed trimer, allowing for
facile inter-exchangeability of apoA1 within a dynamic
sHDL particle. Thus, in the above hypothetical model to
explain apoA1 inter-exchangeability, interchain salt bridges
are replaced by intrachain salt bridges and vice versa, with
little or no energetic penalty.
In summary, we applied SANS with contrast variation and
isotopic protein deuteration to the structural interrogation of
biologically competent reconstituted sHDL. The low resolution
structure of sHDL analyzed by SANS in 12% D2O reveals that
the overall global shape occupied by apoA1 has a nonplanar
contorted conformation. The low resolution structure of sHDL
analyzed by SANS at 42% D2O indicates that the lipid phase of
sHDL is a slightly elongated spheroid encased within the protein component that wraps around it, providing a scaffold upon
which lipids can associate. The protein and lipid organization
revealed may serve as a general structural motif for lipoproteins
VOLUME 286 • NUMBER 14 • APRIL 8, 2011
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cryo-EM and negative staining EM images of sHDL were
shown, no structural models were presented, and the low resolution permitted few details of the overall shape of apoA1
within the particles (29). Zhang et al. (29) did note, however,
that the images of sHDL show “contiguous high densities near
the particle edge and center,” which presumably corresponds to
the protein within sHDL. This description is consistent with the
low resolution structure of apoA1 within sHDL as visualized by
SANS.
The Protein and Lipid Organization in sHDL Provides a General Structural Motif for Lipid Transport—The present study
provides the first direct visualization of the individual structural components of sHDL, the major form of HDL in
plasma, by means of SANS with contrast variation and a
selective isotopic deuterated protein sample. Low resolution
images of the protein and lipid components were obtained
individually to resolve global time-averaged conformations
of each within the whole particle. The overall conformation
noted shows how the protein component of sHDL provides
structural support, much like a cradle or catcher’s mitt,
within which the lipid core is carried. This is a highly unusual
configuration for known macromolecular complexes and
may represent a structural motif replicated in other lipoprotein complexes involved in lipid transport. It is easy to envision how this structural arrangement can enable the lipoprotein to facilitate its lipid cargo-carrying function while also
allowing for the dynamic flexibility of a constantly changing
particle dimension during cholesterol acceptor and lipid
delivery roles. It is intriguing that this sort of global protein
and lipid configuration is somewhat similar to observations
reported by Weisgraber and colleagues (74) during analysis
of apolipoprotein E/diphosphatidylcholine particles in solution using small angle x-ray scattering. In that study, ellipsoidal particles with apolipoprotein E organized in a twisted
hairpin conformation were noted, with proposed packing of
the phospholipid core being micellar (74).
The low resolution structures observed for sHDL, and previously for nascent HDL with contrast variation SANS (32),
suggest a hypothetical path for HDL maturation and reversible remodeling (Fig. 4A). During maturation, cholesterol
ester molecules formed by lecithin:cholesterol acyltransferase at the HDL surface partition into the particle core (Fig.
4A, top). Concurrently, the particle changes from a more
elliptical nascent HDL shape to a spherical form, consistent
with results observed with contrast variation SANS analyses
of both nascent HDL and sHDL (Fig. 4A). As can be seen in
Fig. 4A (bottom), maturation of the HDL particle is predicted
to result in a dramatic change in one of the N and C termini
of the helical dimeric apoA1 (folding back upon itself), probably induced by the addition of a third apoA1 chain in the
more mature sHDL. This refolding of the apoA1 double
chain is suggested based upon the remarkable overlap in
SANS shapes noted between nascent HDL and sHDL
whereby the helical dimeric apoA1 within nascent HDL
closely overlaps with the helical component of the HdHp
conformation of sHDL (Fig. 4A, bottom). As noted above,
previous simulation studies of sHDL have suggested that the
N- and C-terminal regions of apoA1 are more dynamic (49).

Structure of Spherical HDL
that mediate lipid transport and help explain the inter-exchangeability of apoA1 within HDL.
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